Article navigation

Three items are highlighted: I. The recall of L‐tryptophan by the USA Food and Drug Administration because of its near certain causal relation to eosinophilia‐myalgia syndrome; II. The reprinting of an important editorial by D.T. Curry expressing concern at the increasing automatonisation of tasks that formerly required the practice of sophisticated human skills; III. A discussion of the human genome project in terms of costs, time, possible benefits and hazards, and public concern.

This content is only available via PDF.
You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Pay-Per-View Access
$39.00
Rental

or Create an Account

Close Modal
Close Modal